Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Circulating Advanced Oxidation Protein Products (Aopps) Increases the Risk of Metabolic Syndrome Among Adults: A Systematic Review and Meta-Analysis Publisher



Mokhtariardekani A1 ; Fayyazishishavan E2 ; Akhavanfar R3 ; Abbasalizadfarhangi M4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Endocrinology and Metabolism Research Center, Institute of Basic and Clinical Physiology Science and Physiology Research Center, Kerman University of Medical Sciences, Kerman, Iran
  2. 2. Department of Biostatistics and Data Science, School of Public Health, The University of Texas Health Science Center at Houston (UTHealth), Houston, 77030, TX, United States
  3. 3. School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Tabriz Health Services Management Research Center, Tabriz University of Medical Sciences, Attar Nishabouri St., 14711, Tabriz, 5166614711, Iran

Source: International Journal of Diabetes in Developing Countries Published:2023


Abstract

Background: Several studies have highlighted the possible role of advanced oxidation protein products (AOPPs) in promotion of metabolic syndrome (MetS). However, due to inconsistencies in this field, we aimed to quantitatively summarize the results of studies that evaluated the association between AOPPs, with MetS indices among adult population. Methods: In a systematic search from PubMed, Embase, and Scopus electronic databases until 15 August 2022 without language restriction, a total of 1225 articles were obtained. Finally, after duplicate removal of 632 articles and removing of 537 articles according to title/abstract, seven article was included in final meta-analysis. These articles all had observational design, were performed in adults aged more than 18 years old, and evaluated the association between circulating AOPPs and MetS. Results: In our meta-analysis, circulating AOPPs was 17.51 µmol/L higher in individuals with MetS versus individuals without MetS (WMD: 17.512; CI: 12.084, 22.939; p = 0.001). Gender, age, and sample size were recognized as possible heterogeneity sources in subgrouping and meta-regression. No evidence of publication bias was reported. Conclusion: According to the results of the current meta-analysis, higher circulating AOPPs concentrations might be associated with MetS risk among adults. Further longitudinal studies are needed to better identify the causal associations between these variables. © 2023, The Author(s), under exclusive licence to Research Society for Study of Diabetes in India.
Other Related Docs